Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of DNA damage and repair upon the risk of treatment related leukemia.

Leukemia & lymphoma - 1 Feb 2008

Guillem Vicent, Tormo Mar

Abstract excerpt

Therapy-related myelodysplasia and acute myeloid leukemia (t-MDS/AML) are malignancies occurring after exposure to chemotherapy and/or radiotherapy. Several studies have addressed cumulative dose, dose intensity and exposure to specific agents of preceding cytotoxic therapy in relation to the risk of developing such leukemia. Since only a small percentage of patients exposed to cytotoxic therapy develop...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Antineoplastic Agents
Share to Antineoplastic Agents, Alkylating

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Damage

Share to DNA Repair

Share to Neoplasms, Second Primary

Share to Polymorphism, Genetic

Share to Topoisomerase II Inhibitors

Source

Identifiers

PMID: 18231906
DOI: 10.1080/10428190701769657

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of DNA damage and repair upon the risk of treatment related leukemia.PMID 18231906Read ↗

Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia.Semantic proximity Read ↗

Therapy-related myelodysplasia and acute myeloid leukemia.Semantic proximity Read ↗

DNA Damage and Repair in Human Cancer: Molecular Mechanisms and Contribution to Therapy-Related LeukemiasSemantic proximity Read ↗

Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies.Semantic proximity Read ↗

Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.Semantic proximity Read ↗

Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia.Semantic proximity Read ↗

Genetic predisposition and treatment-related leukemia.Semantic proximity Read ↗

Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients.Semantic proximity Read ↗

Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression.Semantic proximity Read ↗

Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.Semantic proximity Read ↗

Therapy Related Leukemias: Susceptibility, Prevention and TreatmentSemantic proximity Read ↗

Role of oncogenes in resistance and killing by cancer therapeutic agentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.